Tadalafil 20 - Genetic Pharmaceuticals

Tadalafil citrate is the active compound in Cialis, a long-acting PDE5 inhibitor developed from IC351 by ICOS in the 1990s. Patented in 1994 and approved in 2003, it changed ED treatment with its unprecedented 36-hour duration. Its β-carboline-based structure contributes to high PDE5 selectivity and fewer side effects like visual disturbances. Approved for daily dosing in 2008, tadalafil citrate gave patients a new option for consistent, spontaneous readiness, marking a key evolution in oral ED therapies.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Tadalafil 20 by Genetic Pharmaceuticals, consult with your doctor or healthcare professional.